Ajanta Pharma moves up on reporting 18% rise in Q1 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Ajanta Pharma is currently trading at Rs. 2620.00, up by 97.25 points or 3.85% from its previous closing of Rs. 2522.75 on the BSE.
The scrip opened at Rs. 2544.75 and has touched a high and low of Rs. 2556.15 and Rs. 2507.00 respectively. So far 2910 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2576.25 on 30-Jul-2024 and a 52 week low of Rs. 1624.80 on 31-Jul-2023.
Last one week high and low of the scrip stood at Rs. 2576.25 and Rs. 2318.45 respectively. The current market cap of the company is Rs. 31512.20 crore.
The promoters holding in the company stood at 66.27%, while Institutions and Non-Institutions held 25.78% and 7.94% respectively.
Ajanta Pharma has reported 11.31% rise in net profit at Rs 236.03 crore for first quarter ended June 30, 2024 as compared to Rs 212.04 crore for the same quarter in the previous year. Total income of the company increased by 5.69% at Rs 1,105.64 crore for Q1FY25 as compared to Rs 1,046.04 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 18.09% rise in its net profit at Rs 245.77 crore for the quarter ended June 30, 2024 as compared to Rs 208.12 crore for the same quarter in the previous year. Total income of the company increased by 11.27% at Rs 1171.39 crore for Q1FY25 as compared to Rs 1052.79 crore for the corresponding quarter previous year.
